This company has been marked as potentially delisted and may not be actively trading. Biophytis (BPTS) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock BPTS Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Biophytis Completes €2.6 Million Private PlacementMarch 31, 2025 | tipranks.comBiophytis Enters Exclusive Negotiations with a Chinese Pharmaceutical Company to License BIO101January 14, 2025 | finance.yahoo.comInstitut Biophytis SAS (ALBPS)August 9, 2024 | investing.comBPTSY Biophytis S.A.July 20, 2024 | seekingalpha.comTrading was temporarily halted for "BPTS" at 07:04 PM with a stated reason of "News pending."April 23, 2024 | marketbeat.comBiotech Catches Major Premarket Bid Following Financial ResultsApril 9, 2024 | theglobeandmail.comWhy Is Penny Stock Biophytis Trading Higher On Tuesday?April 9, 2024 | finance.yahoo.comWhy Is Biophytis (BPTS) Stock Up 43% Today?April 9, 2024 | investorplace.comBiophytis announces its 2023 financial results -2-April 8, 2024 | finanznachrichten.deResults of the Combined General Meeting on April 2, 2024April 4, 2024 | finance.yahoo.comEuropean Equities Traded in the US as American Depositary Receipts Slightly Higher in Friday TradingMarch 22, 2024 | msn.comEuropean Equities Traded in the US as American Depositary Receipts Flat in Tuesday TradingMarch 19, 2024 | msn.comEuropean Equities Traded in the US as American Depositary Receipts Trend Higher in Tuesday TradingMarch 12, 2024 | msn.comEuropean Equities Traded in the US as American Depositary Receipts Edge Higher WednesdayDecember 20, 2023 | msn.comBiophytis and Innovation Solutions Pharma Sign a Partnership Agreement to Accelerate Market Access for Sarconeos (BIO101) in BrazilOctober 30, 2023 | finance.yahoo.comBiophytis ADS Fall 8.5% in After Receiving Nasdaq NoticeOctober 27, 2023 | marketwatch.comBiophytis Receives Notice of Delisting From NASDAQ and Announces It Will Request a Hearing Before the NASDAQ Hearings PanelOctober 27, 2023 | finance.yahoo.comBiophytis shares surge 41% following Covid partnership with France's SkyepharmaSeptember 29, 2023 | proactiveinvestors.comBiophytis (BPTS) Soars 73% on Partnership With SkyepharmaSeptember 26, 2023 | finance.yahoo.comWhy Biophytis (BPTS) Shares Are Sky-RocketingSeptember 25, 2023 | benzinga.comBiophytis Shares Surge 79% Following Covid-19 Partnership With SkyepharmaSeptember 25, 2023 | markets.businessinsider.comTrading was temporarily halted for "BPTS" at 11:09 AM with a stated reason of "LULD pause."September 25, 2023 | marketbeat.comBiophytis Shares Rise 41% After Partnership Deal With SkyepharmaSeptember 25, 2023 | marketwatch.comBiophytis and Skyepharma sign a Partnership Agreement for the Production of Sarconeos (BIO101)September 25, 2023 | finance.yahoo.comWhy Is Biophytis (BPTS) Stock Up 49% Today?September 25, 2023 | msn.comBiophytis and Skyepharma sign a Partnership Agreement for the Production of Sarconeos (BIO101)September 25, 2023 | finance.yahoo.comBiophytis Provides an Update on its Early Access Programs for Sarconeos in the Treatment of Severe Forms of COVID-19September 20, 2023 | finanznachrichten.deBiophytis Provides an Update on its Early Access Programs for Sarconeos (BIO101) in the Treatment of Severe Forms of COVID-19September 19, 2023 | finance.yahoo.comBiophytis Strengthens its Management Team with the Appointment of its Chief Business OfficerSeptember 14, 2023 | finance.yahoo.comBiophytis Obtains FDA Authorization to Initiate the SARA-31 Phase 3 Study in SarcopeniaSeptember 11, 2023 | finanznachrichten.deBiophytis Obtains FDA Authorization to Initiate the SARA-31 Phase 3 Study in SarcopeniaSeptember 11, 2023 | finance.yahoo.comBiophytis to Participate at the H.C. Wainwright 25th Global Investment Conference in New YorkSeptember 4, 2023 | finance.yahoo.comBiophytis Announces Next Regulatory Steps in Europe and the United States for its COVA ProjectAugust 16, 2023 | finance.yahoo.comWhy Is Biophytis (BPTS) Stock Up 18% Today?August 8, 2023 | msn.comBiophytis Receives a Positive Opinion for its SARA-31 Phase 3 Study in Sarcopenia in EuropeAugust 8, 2023 | finance.yahoo.comBiophytis Shares Drop 11% After Request for Meeting With FDA on Covid-19 TreatmentJuly 20, 2023 | marketwatch.comBiophytis has Requested a Pre-Submission Meeting with the FDA for an Emergency Use Authorization of Sarconeos (BIO101) for the Treatment of COVID-19July 20, 2023 | finance.yahoo.comBiophytis has Requested a Pre-Submission Meeting with the FDA for an Emergency Use Authorization of Sarconeos (BIO101) for the Treatment of COVID-19July 20, 2023 | finance.yahoo.comBiophytis Shares Drop 12% on Direct Offering PricingJuly 19, 2023 | marketwatch.comTrading was temporarily halted for "BPTS" at 10:07 AM with a stated reason of "LULD pause."July 19, 2023 | marketbeat.comBiophytis Announces USD3.8 Million Registered Direct OfferingJuly 19, 2023 | finanznachrichten.deBiophytis Announces $3.8 Million Registered Direct OfferingJuly 19, 2023 | finance.yahoo.comiCAD, Biophytis top healthcare gainers; Lixte, Masimo lead losers packJuly 18, 2023 | seekingalpha.comWhy Are Biophytis Shares Skyrocketing Today?July 18, 2023 | benzinga.comBiophytis and SEQENS will together produce Sarconeos active compoundJuly 18, 2023 | msn.comBiophytis Reports Clinical Results for Sarconeos in Sarcopenia Treatment at the 16th SCWD International CongressJune 19, 2023 | finanznachrichten.deBiophytis Reports Clinical Results for Sarconeos (BIO101) in Sarcopenia Treatment at the 16th SCWD International CongressJune 19, 2023 | finance.yahoo.comBiophytis: Results of the Annual General Meeting on June 16, 2023 All Resolutions Presented by the Company Have Been AdoptedJune 16, 2023 | finance.yahoo.comBiophytis to Participate at the BIO International Convention in Boston from the 5th to the 8th of JuneJune 5, 2023 | finance.yahoo.comBiophytis has Filed with the French National Authority for Health (HAS) an Application for Early Access Authorisation (EAA) for Sarconeos (BIO101) in the Treatment of Severe Forms of COVID-19May 26, 2023 | finance.yahoo.com Get Biophytis News Delivered to You Automatically Sign up to receive the latest news and ratings for BPTS and its competitors with MarketBeat's FREE daily newsletter. Email Address BPTS Media Mentions By Week BPTS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BPTS News Sentiment▼0.000.88▲Average Medical News Sentiment BPTS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BPTS Articles This Week▼00▲BPTS Articles Average Week Get Biophytis News Delivered to You Automatically Sign up to receive the latest news and ratings for BPTS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GLYC News Today AEON News Today ORGS News Today TLPH News Today CTXR News Today TRAW News Today APRE News Today KPRX News Today ERNA News Today DWTX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BPTS) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredOil Hits $74 - $100 Next?Oil Jumps 8.5% on Middle East Crisis Trump at Oil Fields Oil surged 8.5% to $74/barrel after Israel's Ir...The Oxford Club | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biophytis S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biophytis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.